Efficacy of Spinal Cord Stimulation in Burst Mode in the Treatment of Complex Regional Pain Syndromes Type 1 of the Upper Limbs
Launched by ELSAN · May 25, 2023
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of a treatment called spinal cord stimulation in a special mode called Burst mode for patients suffering from Complex Regional Pain Syndrome (CRPS) Type I in their upper limbs. CRPS is a condition that causes severe pain, swelling, and changes in the skin. The trial aims to evaluate how well this treatment works and how patients feel about their experience throughout the process.
To participate in the trial, individuals must be between 18 and 75 years old and diagnosed with CRPS affecting at least one arm or hand. They should also be able to understand the treatment and complete some questionnaires. The study is currently looking for volunteers, and participants can expect to be followed for at least a year to assess their progress. It's important to note that individuals with certain health issues, such as uncontrolled infections or those who have had previous spinal cord stimulation, will not be eligible to join. This trial offers an opportunity to explore a potential new option for managing chronic pain in the upper limbs.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients between 18 and 75 years of age
- • Patient with CRPS of at least one upper limb
- • Patient affiliated to a Social Security plan
- • Patient who has signed and dated the no-objection form
- • Patient with the cognitive ability to understand the treatment and complete the questionnaires
- • Patient who can be followed for a minimum of 1 year
- Exclusion Criteria:
- • Patient with an uncontrolled infection
- • Pregnant or breastfeeding patient
- • Patient who has already undergone treatment by spinal cord stimulation
- • Patient with a contraindication to the percutaneous technique (cervical spine surgery, infection...)
- • Patient who cannot be followed regularly for psychological, social, family or geographical reasons
- • Protected participant: adult under guardianship, curatorship or other legal protection, deprived of freedom by judicial or administrative decision.
About Elsan
Elsan is a leading healthcare organization specializing in the management and operation of private medical facilities, with a strong focus on enhancing patient care and clinical outcomes. With a commitment to innovation and excellence, Elsan conducts clinical trials that advance medical research and treatment options across various therapeutic areas. The organization emphasizes collaboration with healthcare professionals and researchers to ensure rigorous study design and ethical standards, ultimately aiming to contribute valuable insights to the medical community and improve patient health on a broader scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nantes, , France
Patients applied
Trial Officials
Jean-Paul NGUYEN, Prof
Study Director
Clinique Bretéché ELSAN
Sylvain DURAND, Dr
Principal Investigator
Clinique Bretéché ELSAN
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported